Opportunities

Discovery Labs is actively seeking value-generating partnerships for the development and commercialization of products to treat respiratory disease. We are specifically interested in:

• Development and commercialization partners for NICU applications of our KL₄ surfactant technologies in major markets.


• Development and commercialization partners for PICU and ICU applications of our KL₄ surfactant technologies on a worldwide basis.


• Worldwide development and commercialization partners for application of our KL₄ surfactant technologies including mucociliary clearance dysfunction diseases such as cystic fibrosis, bronchiectasis and COPD.


• Worldwide development and commercialization partners interested in our drug delivery capabilities.


• Worldwide medical device distribution for our AFECTAIR^® technology.

For additional information please send inquiries to bd@discoverylabs.com